Cancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy
Open accessThe DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
Abstract
Cancer-associated fibroblasts (CAFs) are a heterogenous group of activated fibroblasts and a major component of the tumor stroma. CAFs may be derived from fibroblasts, epithelial cells, endothelial cells, cancer stem cells, adipocytes, pericytes, or stellate cells. These complex origins may underlie their functional diversity, which includes pro-tumorigenic roles in extracellular matrix remodeling, the suppression of anti-tumor immunity, and resistance to cancer therapy. Several methods for targeting CAFs to inhibit tumor progression and enhance anti-tumor immunity have recently been reported. While preclinical studies have shown promise, to date they have been unsuccessful in human clinical trials against melanoma, breast cancer, pancreas cancer, and colorectal cancers. This review summarizes recent and major advances in CAF-targeting therapies, including DNA-based vaccines, anti-CAF CAR-T cells, and modifying and reprogramming CAF functions. The challenges in developing effective anti-CAF treatment are highlighted, which include CAF heterogeneity and plasticity, the lack of specific target markers for CAFs, the limitations in animal models recapitulating the human cancer microenvironment, and the undesirable off-target and systemic side effects. Overcoming these challenges and expanding our understanding of the basic biology of CAFs is necessary for making progress towards safe and effective therapeutic strategies against cancers in human patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yu, B., Wu, K., Wang, X., Zhang, J., Wang, L., Jiang, Y., Zhu, X., Chen, W., & Yan, M. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-1116-6 · Cited by 121
RetractedDominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21708 · Cited by 17,196
Hallmarks of Cancer: New Dimensions
Hanahan, D. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1059 · Cited by 9,887
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Mariathasan, S., Turley, S. J., Nickles, D., Castiglioni, A., Yuen, K., Wang, Y., Kadel III, E. E., Koeppen, H., Astarita, J. L., Cubas, R., et al. (2018) · Nature · doi:10.1038/nature25501 · Cited by 5,400
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Tirosh, I., Izar, B., Prakadan, S. M., Wadsworth, M. H., Treacy, D., Trombetta, J. J., Rotem, A., Rodman, C., Lian, C., Murphy, G., et al. (2016) · Science · doi:10.1126/science.aad0501 · Cited by 4,944
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Tensional homeostasis and the malignant phenotype
Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.010 · Cited by 3,941
A framework for advancing our understanding of cancer-associated fibroblasts
Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0238-1 · Cited by 3,863 · cited 3×
“They support tumor progression and metastasis by promoting cancer cell growth, enhancing pro-tumor immune responses, remodeling the ECM, influencing tumor cell drug resistance, and promoting angiogenesis [3,4].”
BackgroundOrimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Johnson, D. E., O'Keefe, R. A., & Grandis, J. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.8 · Cited by 3,110
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590
Puram, S. V., Tirosh, I., Parikh, A. S., Patel, A. P., Yizhak, K., Gillespie, S., Rodman, C., Luo, C. L., Mroz, E. A., Emerick, K. S., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.044 · Cited by 2,557
Elyada, E., Bolisetty, M., Laise, P., Flynn, W. F., Courtois, E. T., Burkhart, R. A., Teinor, J. A., Belleau, P., Biffi, G., Lucito, M. S., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0094 · Cited by 2,241
Feig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
Tauriello, D. V. F., Palomo-Ponce, S., Stork, D., Berenguer-Llergo, A., Badia-Ramentol, J., Iglesias, M., Sevillano, M., Ibiza, S., Cañellas, A., Hernando-Momblona, X., et al. (2018) · Nature · doi:10.1038/nature25492 · Cited by 1,851
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Costa, A., Kieffer, Y., Scholer-Dahirel, A., Pelon, F., Bourachot, B., Cardon, M., Sirven, P., Magagna, I., Fuhrmann, L., Bernard, C., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.011 · Cited by 1,705
Phenotype molding of stromal cells in the lung tumor microenvironment
Lambrechts, D., Wauters, E., Boeckx, B., Aibar, S., Nittner, D., Burton, O., Bassez, A., Decaluwé, H., Pircher, A., Van den Eynde, K., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0096-5 · Cited by 1,648
Vimentin in cancer and its potential as a molecular target for cancer therapy
Satelli, A., & Li, S. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0735-1 · Cited by 1,557
Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer
Zhang, L., Li, Z., Skrzypczynska, K. M., Fang, Q., Zhang, W., O’Brien, S. A., He, Y., Wang, L., Zhang, Q., Kim, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.048 · Cited by 1,526
Erez, N., Truitt, M., Olson, P., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.041 · Cited by 1,515 · cited 1×
“Additionally, IL-1β from innate immune cells triggers NF-kB activation and production of IL-6 in CAFs via the JAK-STAT pathway, contributing to CAF differentiation [21].”
BackgroundBiffi, G., Oni, T. E., Spielman, B., Hao, Y., Elyada, E., Park, Y., Preall, J., & Tuveson, D. A. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0710 · Cited by 1,360
Distinct fibroblast lineages determine dermal architecture in skin development and repair
Driskell, R. R., Lichtenberger, B. M., Hoste, E., Kretzschmar, K., Simons, B. D., Charalambous, M., Ferron, S. R., Herault, Y., Pavlovic, G., Ferguson-Smith, A. C., et al. (2013) · Nature · doi:10.1038/nature12783 · Cited by 1,291 · cited 1×
“Further studies using lineage tracing for the cell of origin [24,25] will be essential in deepening our understanding on the origins of CAFs, as well as their evolution during tumorigenesis.”
BackgroundDiversity and biology of cancer-associated fibroblasts
Biffi, G., & Tuveson, D. A. (2021) · Physiological Reviews · doi:10.1152/physrev.00048.2019 · Cited by 1,265
Origin and function of myofibroblasts in kidney fibrosis
LeBleu, V. S., Taduri, G., O'Connell, J., Teng, Y., Cooke, V. G., Woda, C., Sugimoto, H., & Kalluri, R. (2013) · Nature Medicine · doi:10.1038/nm.3218 · Cited by 1,263
Su, S., Chen, J., Yao, H., Liu, J., Yu, S., Lao, L., Wang, M., Luo, M., Xing, Y., Chen, F., et al. (2018) · Cell · doi:10.1016/j.cell.2018.01.009 · Cited by 1,230
Sherman, M. H., Yu, R. T., Engle, D. D., Ding, N., Atkins, A. R., Tiriac, H., Collisson, E. A., Connor, F., Van Dyke, T., Kozlov, S., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.007 · Cited by 1,158
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α
Kraman, M., Bambrough, P. J., Arnold, J. N., Roberts, E. W., Magiera, L., Jones, J. O., Gopinathan, A., Tuveson, D. A., & Fearon, D. T. (2010) · Science · doi:10.1126/science.1195300 · Cited by 1,134
Targeting the tumour stroma to improve cancer therapy
Valkenburg, K. C., de Groot, A. E., & Pienta, K. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0007-1 · Cited by 1,084 · cited 15×
“Fibroblasts constitute one of the most abundant and critical cell types in the tumor stroma and are the major producers of connective tissue extracellular matrix (ECM).”
BackgroundInfluentialLi, H., Courtois, E. T., Sengupta, D., Tan, Y., Chen, K. H., Goh, J. J. L., Kong, S. L., Chua, C., Hon, L. K., Tan, W. S., et al. (2017) · Nature Genetics · doi:10.1038/ng.3818 · Cited by 1,080
Identification and characterization of a fibroblast marker: FSP1.
Strutz, F., Okada, H., Lo, C. W., Danoff, T., Carone, R. L., Tomaszewski, J. E., & Neilson, E. G. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.2.393 · Cited by 1,077
Role of Matrix Metalloproteinases in Angiogenesis and Cancer
Quintero-Fabián, S., Arreola, R., Becerril-Villanueva, E., Torres-Romero, J. C., Arana-Argáez, V., Lara-Riegos, J., Ramírez-Camacho, M. A., & Alvarez-Sánchez, M. E. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01370 · Cited by 1,036
Chauhan, V. P., Martin, J. D., Liu, H., Lacorre, D. A., Jain, S. R., Kozin, S. V., Stylianopoulos, T., Mousa, A. S., Han, X., Adstamongkonkul, P., et al. (2013) · Nature Communications · doi:10.1038/ncomms3516 · Cited by 1,031
The polarization of immune cells in the tumour environment by TGFβ
Flavell, R. A., Sanjabi, S., Wrzesinski, S. H., & Licona-Limón, P. (2010) · Nature Reviews Immunology · doi:10.1038/nri2808 · Cited by 940
Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer.
Kieffer, Y., Hocine, H. R., Gentric, G., Pelon, F., Bernard, C., Bourachot, B., Lameiras, S., Albergante, L., Bonneau, C., Guyard, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1384 · Cited by 910
A decade of transcription factor-mediated reprogramming to pluripotency
Takahashi, K., & Yamanaka, S. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.8 · Cited by 878
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
Liu, T., Han, C., Wang, S., Fang, P., Ma, Z., Xu, L., & Yin, R. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0770-1 · Cited by 860 · cited 1×
“Fibrocytes, circulating mesenchymal cells derived from monocyte precursors, can also become CAFs [15].”
BackgroundDominguez, C. X., Müller, S., Keerthivasan, S., Koeppen, H., Hung, J., Gierke, S., Breart, B., Foreman, O., Bainbridge, T. W., Castiglioni, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0644 · Cited by 857
Bartoschek, M., Oskolkov, N., Bocci, M., Lövrot, J., Larsson, C., Sommarin, M., Madsen, C. D., Lindgren, D., Pekar, G., Karlsson, G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07582-3 · Cited by 826
Li, J., Byrne, K. T., Yan, F., Yamazoe, T., Chen, Z., Baslan, T., Richman, L. P., Lin, J. H., Sun, Y. H., Rech, A. J., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.06.006 · Cited by 750
Yang, X., Lin, Y., Shi, Y., Li, B., Liu, W., Yin, W., Dang, Y., Chu, Y., Fan, J., & He, R. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2973 · Cited by 748
In search of definitions: Cancer‐associated fibroblasts and their markers
Nurmik, M., Ullmann, P., Rodriguez, F., Haan, S., & Letellier, E. (2020) · International Journal of Cancer · doi:10.1002/ijc.32193 · Cited by 739 · cited 1×
“To date, CAFs are defined as cells that lack the expression of biomarkers for epithelial, endothelial, or hematopoietic cells but express mesenchymal biomarkers such as vimentin, α-SMA, FAP, and platelet-derived growth factor receptor alpha (PDGFR-α), and lack genetic mutations [27,28].”
BackgroundDiop-Frimpong, B., Chauhan, V. P., Krane, S., Boucher, Y., & Jain, R. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018892108 · Cited by 733
Carcinoma-associated fibroblasts: orchestrating the composition of malignancy
Gascard, P., & Tlsty, T. D. (2016) · Genes & Development · doi:10.1101/gad.279737.116 · Cited by 732
Identification of fibroblast heterogeneity in the tumor microenvironment
Sugimoto, H., Mundel, T. M., Kieran, M. W., & Kalluri, R. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.12.3354 · Cited by 699
Tumor-associated neutrophils: friend or foe?
Fridlender, Z. G., & Albelda, S. M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs123 · Cited by 699
Chen, Z., Zhou, L., Liu, L., Hou, Y., Xiong, M., Yang, Y., Hu, J., & Chen, K. (2020) · Nature Communications · doi:10.1038/s41467-020-18916-5 · Cited by 694
Monteran, L., & Erez, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01835 · Cited by 675
Kumar, V., Donthireddy, L., Marvel, D., Condamine, T., Wang, F., Lavilla-Alonso, S., Hashimoto, A., Vonteddu, P., Behera, R., Goins, M. A., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.10.005 · Cited by 653
Wang, L.-C. S., Lo, A., Scholler, J., Sun, J., Majumdar, R. S., Kapoor, V., Antzis, M., Cotner, C. E., Johnson, L. A., Durham, A. C., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0027 · Cited by 653
Loeffler, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26532 · Cited by 633
A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response
Ding, N., Yu, R. T., Subramaniam, N., Sherman, M. H., Wilson, C., Rao, R., Leblanc, M., Coulter, S., He, M., Scott, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.028 · Cited by 622
Ene–Obong, A., Clear, A. J., Watt, J., Wang, J., Fatah, R., Riches, J. C., Marshall, J. F., Chin–Aleong, J., Chelala, C., Gribben, J. G., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.025 · Cited by 579
Mace, T. A., Shakya, R., Pitarresi, J. R., Swanson, B., McQuinn, C. W., Loftus, S., Nordquist, E., Cruz-Monserrate, Z., Yu, L., Young, G., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-311585 · Cited by 539
Comito, G., Giannoni, E., Segura, C. P., Barcellos-de-Souza, P., Raspollini, M. R., Baroni, G., Lanciotti, M., Serni, S., & Chiarugi, P. (2014) · Oncogene · doi:10.1038/onc.2013.191 · Cited by 528
Murphy, J. E., Wo, J. Y., Ryan, D. P., Clark, J. W., Jiang, W., Yeap, B. Y., Drapek, L. C., Ly, L., Baglini, C. V., Blaszkowsky, L. S., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.0892 · Cited by 522
Chen, S., Zhu, G., Yang, Y., Wang, F., Xiao, Y.-T., Zhang, N., Bian, X., Zhu, Y., Yu, Y., Liu, F., et al. (2021) · Nature Cell Biology · doi:10.1038/s41556-020-00613-6 · Cited by 502
Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells
Lo, A., Wang, L.-C. S., Scholler, J., Monslow, J., Avery, D., Newick, K., O'Brien, S., Evans, R. A., Bajor, D. J., Clendenin, C., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3041 · Cited by 498
The Intersection between Tumor Angiogenesis and Immune Suppression
Rahma, O. E., & Hodi, F. S. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1543 · Cited by 472
Tran, E., Chinnasamy, D., Yu, Z., Morgan, R. A., Lee, C.-C. R., Restifo, N. P., & Rosenberg, S. A. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130110 · Cited by 463
Scott, A. M., Wiseman, G., Welt, S., Adjei, A. A., Lee, F.-T., Hopkins, W., Divgi, C. R., Hanson, L. J., Mitchell, P., Gansen, D. N., et al. (2003) · PubMed · Cited by 438
Stromal cell diversity associated with immune evasion in human triple‐negative breast cancer
Wu, S. Z., Roden, D. L., Wang, C., Holliday, H., Harvey, K., Cazet, A. S., Murphy, K. J., Pereira, B., Al‐Eryani, G., Bartonicek, N., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019104063 · Cited by 436
Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring
Shi, Y., Gao, W., Lytle, N. K., Huang, P., Yuan, X., Dann, A. M., Ridinger-Saison, M., DelGiorno, K. E., Antal, C. E., Liang, G., et al. (2019) · Nature · doi:10.1038/s41586-019-1130-6 · Cited by 431
DNA Damage-Mediated Induction of a Chemoresistant Niche
Gilbert, L. A., & Hemann, M. T. (2010) · Cell · doi:10.1016/j.cell.2010.09.043 · Cited by 428
Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor Microenvironment
Augsten, M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00062 · Cited by 427
Froeling, F. E. M., Feig, C., Chelala, C., Dobson, R., Mein, C. E., Tuveson, D. A., Clevers, H., Hart, I. R., & Kocher, H. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.047 · Cited by 418
Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations
Affo, S., Nair, A., Brundu, F., Ravichandra, A., Bhattacharjee, S., Matsuda, M., Chin, L., Filliol, A., Wen, W., Song, X., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.03.012 · Cited by 416
Roberts, E. W., Deonarine, A., Jones, J. O., Denton, A. E., Feig, C., Lyons, S. K., Espeli, M., Kraman, M., McKenna, B., Wells, R. J. B., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122344 · Cited by 414
Löhr, M. J., Schmidt, C., Ringel, J., Kluth, M., Müller, P., Nizze, H., & Jesnowski, R. (2001) · PubMed · Cited by 413
Mace, T. A., Ameen, Z., Collins, A., Wojcik, S., Mair, M., Young, G. S., Fuchs, J. R., Eubank, T. D., Frankel, W. L., Bekaii-Saab, T., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4601 · Cited by 410
Chen, I. X., Chauhan, V. P., Posada, J., Ng, M. R., Wu, M. W., Adstamongkonkul, P., Huang, P., Lindeman, N., Langer, R., & Jain, R. K. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815515116 · Cited by 406
De Wever, O., Nguyen, Q., Van Hoorde, L., Bracke, M., Bruyneel, E., Gespach, C., & Mareel, M. (2004) · The FASEB Journal · doi:10.1096/fj.03-1110fje · Cited by 402
Podoplanin: emerging functions in development, the immune system, and cancer
Astarita, J. L., Acton, S. E., & Turley, S. J. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00283 · Cited by 402
Cheng, Y., Li, H., Deng, Y., Tai, Y., Zeng, K., Zhang, Y., Liu, W., Zhang, Q., & Yang, Y. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0458-4 · Cited by 399
Pelon, F., Bourachot, B., Kieffer, Y., Magagna, I., Mermet-Meillon, F., Bonnet, I., Costa, A., Givel, A.-M., Attieh, Y., Barbazan, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14134-w · Cited by 390
Hofheinz, R.-D., al-Batran, S.-E., Hartmann, F., Hartung, G., Jäger, D., Renner, C., Tanswell, P., Kunz, U., Amelsberg, A., Kuthan, H., et al. (2003) · Oncology Research and Treatment · doi:10.1159/000069863 · Cited by 374
Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity
Flint, T. R., Janowitz, T., Connell, C. M., Roberts, E. W., Denton, A. E., Coll, A. P., Jodrell, D. I., & Fearon, D. T. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.010 · Cited by 367
Hu, Y., Yan, C., Mu, L., Huang, K., Li, X., Tao, D., Wu, Y., & Qin, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0125625 · Cited by 348
Friedman, G., Levi-Galibov, O., David, E., Bornstein, C., Giladi, A., Dadiani, M., Mayo, A., Halperin, C., Pevsner-Fischer, M., Lavon, H., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0082-y · Cited by 347
Zhang, R., Qi, F., Zhao, F., Li, G., Shao, S., Zhang, X., Yuan, L., & Feng, Y. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1435-2 · Cited by 343
Han, X., Li, Y., Xu, Y., Zhao, X., Zhang, Y., Yang, X., Wang, Y., Zhao, R., Anderson, G. J., Zhao, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05906-x · Cited by 339
Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver
Österreicher, C. H., Penz-Österreicher, M., Grivennikov, S. I., Guma, M., Koltsova, E. K., Datz, C., Sasik, R., Hardiman, G., Karin, M., & Brenner, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017547108 · Cited by 337
Song, M., He, J., Pan, Q., Yang, J., Zhao, J., Zhang, Y., Huang, Y., Tang, Y., Wang, Q., He, J., et al. (2021) · Hepatology · doi:10.1002/hep.31792 · Cited by 336
Cancer-associated fibroblasts in tumor microenvironment–Accomplices in tumor malignancy
Liao, Z., Tan, Z. W., Zhu, P., & Tan, N. S. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2017.12.003 · Cited by 335
Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
Balsamo, M., Scordamaglia, F., Pietra, G., Manzini, C., Cantoni, C., Boitano, M., Queirolo, P., Vermi, W., Facchetti, F., Moretta, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906481106 · Cited by 330
Single-Cell RNA Sequencing Reveals a Dynamic Stromal Niche That Supports Tumor Growth
Davidson, S., Efremova, M., Riedel, A., Mahata, B., Pramanik, J., Huuhtanen, J., Kar, G., Vento-Tormo, R., Hagai, T., Chen, X., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107628 · Cited by 323
Goulet, C. R., Champagne, A., Bernard, G., Vandal, D., Chabaud, S., Pouliot, F., & Bolduc, S. (2019) · BMC Cancer · doi:10.1186/s12885-019-5353-6 · Cited by 322
Exosomes Induce Fibroblast Differentiation into Cancer-Associated Fibroblasts through TGFβ Signaling
Ringuette Goulet, C., Bernard, G., Tremblay, S., Chabaud, S., Bolduc, S., & Pouliot, F. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0784 · Cited by 321
Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
Godwin, P., Baird, A. M., Heavey, S., Barr, M. P., O’Byrne, K. J., & Gately, K. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00120 · Cited by 296
miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
Givel, A.-M., Kieffer, Y., Scholer-Dahirel, A., Sirven, P., Cardon, M., Pelon, F., Magagna, I., Gentric, G., Costa, A., Bonneau, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03348-z · Cited by 295
Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins
Zeltz, C., Primac, I., Erusappan, P., Alam, J., Noel, A., & Gullberg, D. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.004 · Cited by 290
Herrera, M., Herrera, A., Domínguez, G., Silva, J., García, V., García, J. M., Gómez, I., Soldevilla, B., Muñoz, C., Provencio, M., et al. (2013) · Cancer Science · doi:10.1111/cas.12096 · Cited by 289
Brennen, W. N., Isaacs, J. T., & Denmeade, S. R. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0340 · Cited by 289
Cancer-associated fibroblasts: overview, progress, challenges, and directions
Ping, Q., Yan, R., Cheng, X., Wang, W., Zhong, Y., Hou, Z., Shi, Y., Wang, C., & Li, R. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-021-00318-4 · Cited by 285
Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment
Helms, E., Onate, M. K., & Sherman, M. H. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1353 · Cited by 283
Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
Steele, N. G., Biffi, G., Kemp, S. B., Zhang, Y., Drouillard, D., Syu, L., Hao, Y., Oni, T. E., Brosnan, E., Elyada, E., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3715 · Cited by 283
Tang, Y.-A., Chen, Y.-F., Bao, Y., Mahara, S., Yatim, S. M. J. M., Oguz, G., Lee, P. L., Feng, M., Cai, Y., Tan, E. Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801348115 · Cited by 277
Narra, K., Mullins, S. R., Lee, H.-O., Strzemkowski-Brun, B., Magalong, K., Christiansen, V. J., McKee, P. A., Egleston, B., Cohen, S. J., Weiner, L. M., et al. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.11.4874 · Cited by 275
Cheng, J.-T., Deng, Y.-N., Yi, H.-M., Wang, G.-Y., Fu, B.-S., Chen, W.-J., Liu, W., Tai, Y., Peng, Y.-W., & Zhang, Q. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.7 · Cited by 267
Zhang, Y., Yan, W., Collins, M. A., Bednar, F., Rakshit, S., Zetter, B. R., Stanger, B. Z., Chung, I., Rhim, A. D., & di Magliano, M. P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1558-t · Cited by 261
Xiang, H., Ramil, C. P., Hai, J., Zhang, C., Wang, H., Watkins, A. A., Afshar, R., Georgiev, P., Sze, M. A., Song, X. S., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0507 · Cited by 256
Effective Immunoconjugate Therapy in Cancer Models Targeting a Serine Protease of Tumor Fibroblasts
Ostermann, E., Garin-Chesa, P., Heider, K. H., Kalat, M., Lamche, H., Puri, C., Kerjaschki, D., Rettig, W. J., & Adolf, G. R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5211 · Cited by 246
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.11.002 · Cited by 245
Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts
Shi, X., Young, C. D., Zhou, H., & Wang, X.-J. (2020) · Biomolecules · doi:10.3390/biom10121666 · Cited by 243
Ao, Z., Shah, S. H., Machlin, L. M., Parajuli, R., Miller, P. C., Rawal, S., Williams, A. J., Cote, R. J., Lippman, M. E., Datar, R. H., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1633 · Cited by 234
Cancer-Associated Fibroblasts Induce a Collagen Cross-link Switch in Tumor Stroma
Pankova, D., Chen, Y., Terajima, M., Schliekelman, M. J., Baird, B. N., Fahrenholtz, M., Sun, L., Gill, B. J., Vadakkan, T. J., Kim, M. P., et al. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0307 · Cited by 232
Francescone, R., Barbosa Vendramini-Costa, D., Franco-Barraza, J., Wagner, J., Muir, A., Lau, A. N., Gabitova, L., Pazina, T., Gupta, S., Luong, T., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0775 · Cited by 222
Giesel, F. L., Kratochwil, C., Schlittenhardt, J., Dendl, K., Eiber, M., Staudinger, F., Kessler, L., Fendler, W. P., Lindner, T., Koerber, S. A., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05307-1 · Cited by 219
Cheng, J. D., Dunbrack, R. L., Valianou, M., Rogatko, A., Alpaugh, R. K., & Weiner, L. M. (2002) · PubMed · Cited by 217
Grauel, A. L., Nguyen, B., Ruddy, D., Laszewski, T., Schwartz, S., Chang, J., Chen, J., Piquet, M., Pelletier, M., Yan, Z., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19920-5 · Cited by 211
Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts
Avery, D., Govindaraju, P., Jacob, M., Todd, L., Monslow, J., & Puré, E. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.12.003 · Cited by 206
Chauhan, V. P., Chen, I. X., Tong, R., Ng, M. R., Martin, J. D., Naxerova, K., Wu, M. W., Huang, P., Boucher, Y., Kohane, D. S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819889116 · Cited by 206
Adams, S., Miller, G. T., Jesson, M. I., Watanabe, T., Jones, B., & Wallner, B. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0447 · Cited by 202
The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer
Sun, Q., Zhang, B., Hu, Q., Qin, Y., Xu, W., Liu, W., Yu, X., & Xu, J. (2018) · Theranostics · doi:10.7150/thno.26546 · Cited by 193
Extracellular Matrices and Cancer-Associated Fibroblasts: Targets for Cancer Diagnosis and Therapy?
Belhabib, I., Zaghdoudi, S., Lac, C., Bousquet, C., & Jean, C. (2021) · Cancers · doi:10.3390/cancers13143466 · Cited by 191
Navab, R., Strumpf, D., To, C., Pasko, E., Kim, K. S., Park, C. J., Hai, J., Liu, J., Jonkman, J., Barczyk, M., et al. (2016) · Oncogene · doi:10.1038/onc.2015.254 · Cited by 190
Zhang, D., Li, L., Jiang, H., Li, Q., Wang-Gillam, A., Yu, J., Head, R., Liu, J., Ruzinova, M. B., & Lim, K.-H. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1366 · Cited by 190
Dynamic Mast Cell–Stromal Cell Interactions Promote Growth of Pancreatic Cancer
Ma, Y., Hwang, R. F., Logsdon, C. D., & Ullrich, S. E. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4479 · Cited by 186
Tenascin C in metastasis: A view from the invasive front
Lowy, C. M., & Oskarsson, T. (2015) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1008331 · Cited by 178
Tenascin-C and integrins in cancer
Yoshida, T., Akatsuka, T., & Imanaka-Yoshida, K. (2015) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1008332 · Cited by 178
Shindo, K., Aishima, S., Ohuchida, K., Fujiwara, K., Fujino, M., Mizuuchi, Y., Hattori, M., Mizumoto, K., Tanaka, M., & Oda, Y. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-168 · Cited by 174
Yeon, J. H., Jeong, H. E., Seo, H., Cho, S., Kim, K., Na, D., Chung, S., Park, J., Choi, N., & Kang, J. Y. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.07.001 · Cited by 173
Planche, A., Bacac, M., Provero, P., Fusco, C., Delorenzi, M., Stehle, J.-C., & Stamenkovic, I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018640 · Cited by 171
Freedman, J. D., Duffy, M. R., Lei-Rossmann, J., Muntzer, A., Scott, E. M., Hagel, J., Campo, L., Bryant, R. J., Verrill, C., Lambert, A., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1750 · Cited by 170
Combined Effects of Pericytes in the Tumor Microenvironment
Ribeiro, A. L., & Okamoto, O. K. (2015) · Stem Cells International · doi:10.1155/2015/868475 · Cited by 168
Zhu, C.-Q., Popova, S. N., Brown, E. R. S., Barsyte-Lovejoy, D., Navab, R., Shih, W., Li, M., Lu, M., Jurisica, I., Penn, L. Z., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703040104 · Cited by 167
Arnold, J. N., Magiera, L., Kraman, M., & Fearon, D. T. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0150 · Cited by 166
Lee, J., Fassnacht, M., Nair, S., Boczkowski, D., & Gilboa, E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2805 · Cited by 159
Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin
LeBeau, A. M., Brennen, W. N., Aggarwal, S., & Denmeade, S. R. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1170 · Cited by 159
Carcinoma-Associated Fibroblasts Are a Promising Therapeutic Target
Togo, S., Polanska, U., Horimoto, Y., & Orimo, A. (2013) · Cancers · doi:10.3390/cancers5010149 · Cited by 156
Mesenchymal Stem or Stromal Cells: Toward a Better Understanding of Their Biology?
Lindner, U., Kramer, J., Rohwedel, J., & Schlenke, P. (2010) · Transfusion Medicine and Hemotherapy · doi:10.1159/000290897 · Cited by 151
Tumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences
Paunescu, V., Bojin, F. M., Tatu, C. A., Gavriliuc, O. I., Rosca, A., Gruia, A. T., Tanasie, G., Bunu, C., Crisnic, D., Gherghiceanu, M., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01044.x · Cited by 150
Kisselbach, L., Merges, M., Bossie, A., & Boyd, A. L. (2009) · Cytotechnology · doi:10.1007/s10616-009-9190-3 · Cited by 150
Cancer-associated Fibroblasts Promote Irradiated Cancer Cell Recovery Through Autophagy
Wang, Y., Gan, G., Wang, B., Wu, J., Cao, Y., Zhu, D., Xu, Y., Wang, X., Han, H., Li, X., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.02.019 · Cited by 144
Vázquez, F., García-Ocaña, M., Galván, J. A., García–Martínez, J., García-Pravia, C., Menéndez‐Rodríguez, P., del Rey, C. G., Barneo, L., & Toyos, J. R. D. L. (2015) · Tumor Biology · doi:10.1007/s13277-015-3295-4 · Cited by 139
Farahani, R. M., & Xaymardan, M. (2015) · Stem Cells International · doi:10.1155/2015/362753 · Cited by 138
Brünker, P., Wartha, K., Friess, T., Grau-Richards, S., Waldhauer, I., Koller, C. F., Weiser, B., Majety, M., Runza, V., Niu, H., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0647 · Cited by 137
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
Wang, Z., Tang, Y., Tan, Y., Wei, Q., & Yu, W. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0362-2 · Cited by 135
Jia, D., Liu, Z., Deng, N., Tan, T. Z., Huang, R. Y.-J., Taylor-Harding, B., Cheon, D.-J., Lawrenson, K., Wiedemeyer, W. R., Walts, A. E., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.09.001 · Cited by 130
D’Arcangelo, E., Wu, N. C., Cadavid, J. L., & McGuigan, A. P. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0705-1 · Cited by 126
Bayer, S. V., Grither, W. R., Brenot, A., Hwang, P. Y., Barcus, C. E., Ernst, M., Pence, P., Walter, C., Pathak, A., & Longmore, G. D. (2019) · eLife · doi:10.7554/elife.45508 · Cited by 125
Norton, J., Foster, D., Chinta, M., Titan, A., & Longaker, M. (2020) · Cancers · doi:10.3390/cancers12051347 · Cited by 125
Li, T., Yi, S., Liu, W., Jia, C., Wang, G., Hua, X., Tai, Y., Zhang, Q., & Chen, G. (2013) · Medical Oncology · doi:10.1007/s12032-013-0663-z · Cited by 121
Mathew, E., Brannon, A. L., Del Vecchio, A., Garcia, P. E., Penny, M. K., Kane, K. T., Vinta, A., Buckanovich, R. J., & di Magliano, M. P. (2016) · Neoplasia · doi:10.1016/j.neo.2016.01.005 · Cited by 121
A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice
Fang, J., Xiao, L., Joo, K., Liu, Y., Zhang, C., Liu, S., Conti, P. S., Li, Z., & Wang, P. (2016) · International Journal of Cancer · doi:10.1002/ijc.29831 · Cited by 120
β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer
Blandin, A.-F., Renner, G., Lehmann, M., Lelong-Rebel, I. H., Martin, S., & Dontenwill, M. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00279 · Cited by 119
Qin, X., Yan, M., Zhang, J., Wang, X., Shen, Z., Lv, Z., Li, Z., Wei, W., & Chen, W. (2016) · Scientific Reports · doi:10.1038/srep20587 · Cited by 117
Cancer-associated fibroblasts: key determinants of tumor immunity and immunotherapy
Barrett, R., & Puré, E. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.03.004 · Cited by 117
Ansems, M., & Span, P. N. (2020) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2020.04.001 · Cited by 116
Peiris-Pagès, M., Sotgia, F., & Lisanti, M. P. (2015) · Oncotarget · doi:10.18632/oncotarget.3828 · Cited by 115
Dauer, P., Zhao, X., Gupta, V. K., Sharma, N., Kesh, K., Gnamlin, P., Dudeja, V., Vickers, S. M., Banerjee, S., & Saluja, A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2320 · Cited by 115
CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule
Sauzay, C., Voutetakis, K., Chatziioannou, A. A., Chevet, É., & Avril, T. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00066 · Cited by 115
CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway
Wang, L., Zhang, F., Cui, J., Chen, L., Chen, Y., & Liu, B. (2018) · Oncology Reports · doi:10.3892/or.2018.6311 · Cited by 112
IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma
Long, K. B., Tooker, G., Tooker, E., Luque, S. L., Lee, J. W., Pan, X., & Beatty, G. L. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0899 · Cited by 111
Kinoshita, T., Ishii, G., Hiraoka, N., Hirayama, S., Yamauchi, C., Aokage, K., Hishida, T., Yoshida, J., Nagai, K., & Ochiai, A. (2013) · Cancer Science · doi:10.1111/cas.12099 · Cited by 108
Banerjee, S., Modi, S., McGinn, O., Zhao, X., Dudeja, V., Ramakrishnan, S., & Saluja, A. K. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1155 · Cited by 108
Jia, C., Wang, G., Wang, T., Fu, B., Zhang, Y., Huang, L., Deng, Y., Chen, G., Wu, X., Chen, J., et al. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45446 · Cited by 106
Zhang, Y., & Ertl, H. C. J. (2016) · Oncotarget · doi:10.18632/oncotarget.7818 · Cited by 105
Podoplanin‐expressing inflammatory macrophages activate murine platelets via CLEC‐2
Kerrigan, A. M., Navarro‐Núñez, L., Pyż, E., Finney, B. A., Willment, J. A., Watson, S. P., & BROWN, G. D. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04614.x · Cited by 102
Li, D., Qu, C., Ning, Z., Wang, H., Zang, K., Zhuang, L., Chen, L., Wang, P., & Meng, Z. (2016) · PubMed Central · Cited by 101
Simpkins, S. A., Hanby, A. M., Holliday, D. L., & Speirs, V. (2012) · The Journal of Pathology · doi:10.1002/path.4034 · Cited by 100
Hsia, L.-T., Ashley, N., Ouaret, D., Wang, L. M., Wilding, J., & Bodmer, W. F. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603534113 · Cited by 99
Chen, B., Wang, Z., Sun, J., Song, Q., He, B., Zhang, H., Wang, X., Dai, W., & Zhang, Q. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.10.001 · Cited by 97
Truffi, M., Mazzucchelli, S., Bonizzi, A., Sorrentino, L., Allevi, R., Vanna, R., Morasso, C., & Corsi, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061263 · Cited by 94
Kitano, H., Kageyama, S.-I., Hewitt, S. M., Hayashi, R., Doki, Y., Ozaki, Y., Fujino, S., Takikita, M., Kubo, H., & Fukuoka, J. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2009-0114-oa.1 · Cited by 92
Aoyagi, Y., Oda, T., Kinoshita, T., Nakahashi, C., Hasebe, T., Ohkohchi, N., & Ochiai, A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602141 · Cited by 90
Zhang, J., Chen, L., Liu, X., Kammertoens, T., Blankenstein, T. J. F., & Qin, Z. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3022 · Cited by 87
Watanabe, S., Noma, K., Ohara, T., Kashima, H., Sato, H., Kato, T., Urano, S., Katsube, R., Hashimoto, Y., Tazawa, H., et al. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1617566 · Cited by 87
Valdés‐Mora, F., Salomon, R., Gloss, B., Law, A. M. K., Venhuizen, J., Castillo, L. E., Murphy, K. J., Magenau, A., Papanicolaou, M., de la Fuente, L. R., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108945 · Cited by 86
Katsube, R., Noma, K., Ohara, T., Nishiwaki, N., Kobayashi, T., Komoto, S., Sato, H., Kashima, H., Kato, T., Kikuchi, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81465-4 · Cited by 84
Garvey, C. M., Lau, R., Sanchez, A., Sun, R. X., Fong, E. J., Doche, M. E., Chen, O., Jusuf, A., Lenz, H.-J., Larson, B., et al. (2020) · Cancers · doi:10.3390/cancers12061393 · Cited by 83
Zhang, K., Grither, W. R., Van Hove, S., Biswas, H., Ponik, S. M., Eliceiri, K. W., Keely, P. J., & Longmore, G. D. (2016) · Journal of Cell Science · doi:10.1242/jcs.180539 · Cited by 79
Chen, D., & Che, G. (2014) · Oncology Letters · doi:10.3892/ol.2014.2385 · Cited by 72
Waise, S., Parker, R., Rose-Zerilli, M. J. J., Layfield, D. M., Wood, O., West, J., Ottensmeier, C. H., Thomas, G. J., & Hanley, C. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-45842-4 · Cited by 70
Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug
Huang, S., Fang, R. M., Xu, J., Qiu, S., Zhang, H., Du, J., & Cai, S. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2010.511225 · Cited by 67
Pereira, B., Lister, N. L., Hashimoto, K., Teng, L., Flandes‐Iparraguirre, M., Eder, A., Sánchez‐Herrero, A., Niranjan, B., Frydenberg, M., Papargiris, M., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.12.030 · Cited by 60
Expression of cancer-associated fibroblast markers in advanced colorectal cancer
Nishishita, R., Morohashi, S., Seino, H., Wu, Y., Yoshizawa, T., Haga, T., Saito, K., Hakamada, K., Fukuda, S., & Kijima, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.8097 · Cited by 59
Ishibashi, M., Neri, S., Hashimoto, H., Miyashita, T., Yoshida, T., Nakamura, Y., Udagawa, H., Kirita, K., Matsumoto, S., Umemura, S., et al. (2017) · Scientific Reports · doi:10.1038/srep46662 · Cited by 57
Huber, R. M., Lucas, J. M., Gomez-Sarosi, L. A., Coleman, I., Zhao, S., Coleman, R., & Nelson, P. S. (2015) · Oncotarget · doi:10.18632/oncotarget.3040 · Cited by 56
Thy-1+ Cancer-associated Fibroblasts Adversely Impact Lung Cancer Prognosis
Schliekelman, M. J., Creighton, C. J., Baird, B. N., Chen, Y., Banerjee, P., Bota‐Rabassedas, N., Ahn, Y., Roybal, J. D., Chen, F., Zhang, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06922-5 · Cited by 51
Qiu, X., Zhang, F.-F., Geng, F., Liu, C., Xu, P., Lu, Z.-Z., Yu, B., Wu, H., Wu, J., Zhang, H., et al. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1827-4 · Cited by 50
Pickup, M. W., Owens, P., Gorska, A. E., Chytil, A., Ye, F., Shi, C., Weaver, V. M., Kalluri, R., Moses, H. L., & Novitskiy, S. V. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0311 · Cited by 50
Chen, S.-X., Xu, X., Wang, X., Cui, S., Xu, L., Jiang, Y.-H., Zhang, Y., Yan, H., Zhang, Q., Qiao, J., et al. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.07.031 · Cited by 49
Yang, N., Lode, K., Berzaghi, R., Islam, A., Martínez-Zubiaurre, I., & Hellevik, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.602530 · Cited by 48
Geng, F., Bao, X., Dong, L., Guo, Q., Guo, J., Xie, Y., Zhou, Y., Yu, B., Wu, H., Wu, J., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1747350 · Cited by 45
Interaction between Fibroblasts and Immune Cells Following DNA Damage Induced by Ionizing Radiation
Ragunathan, K., Upfold, N. L. E., & Oksenych, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228635 · Cited by 45
Kim, O.-H., Kang, G.-H., Noh, H., Cha, J.-Y., Lee, H.-J., Yoon, J.-H., Mamura, M., Nam, J.-S., Lee, D. H., Kim, Y. A., et al. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0194-7 · Cited by 43
Fang, J., Hu, B., Li, S., Zhang, C., Liu, Y., & Wang, P. (2016) · Molecular Therapy — Oncolytics · doi:10.1038/mto.2016.7 · Cited by 43
Deconstructing tumor heterogeneity: the stromal perspective
Vickman, R. E., Faget, D. V., Beachy, P., Beebe, D., Bhowmick, N. A., Cukierman, E., Deng, W.-M., Granneman, J. G., Hildesheim, J., Kalluri, R., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27736 · Cited by 42
Rabenhold, M., Steiniger, F., Fahr, A., Kontermann, R. E., & Rüger, R. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.022 · Cited by 35
Tansi, F. L., Rüger, R., Böhm, C., Steiniger, F., Kontermann, R. E., Teichgraeber, U. K., Fahr, A., & Hilger, I. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.03.033 · Cited by 31
Cited by
The tumor microenvironment: shaping cancer progression and treatment response
Desai, S. A., Patel, V. P., Bhosle, K. P., Nagare, S. D., & Thombare, K. C. (2025) · Journal of Chemotherapy · doi:10.1080/1120009x.2023.2300224 · Cited by 106
Metadata
- Authors
- Glabman, R. A., Choyke, P. L., & Sato, N.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2022-08-12
- Volume
- 14
- Issue
- 16
- Pages
- 3906
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W4291415522
- Cited by
- 254
- References
- 192
- FWCI
- 18.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.